Stock BTPC ACTIVE BIOTECH AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Active Biotech AB Xetra

Equities

BTPC

SE0001137985

Biotechnology & Medical Research

End-of-day quote Xetra
Other stock markets
- EUR - Intraday chart for Active Biotech AB
22/05 Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug MT
22/05 Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology CI

Business Summary

Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.

Managers

Managers TitleAgeSince
Helén Tuvesson CEO
 Chief Executive Officer 62 01/98/01
Hans Kolam DFI
 Director of Finance/CFO 73 01/00/01
Erik Vahtola CTO
 Chief Tech/Sci/R&D Officer - 01/22/01

Members of the board

Members of the board TitleAgeSince
Uli Alf Hacksell BRD
 Director/Board Member 74 23/19/23
Aleksandar Danilovski BRD
 Director/Board Member 50 01/20/01
Michael Shalmi CHM
 Chairman 59 23/19/23
Karl Peter Thelin BRD
 Director/Board Member 68 05/11/05
Axel Gaston Glasmacher BRD
 Director/Board Member 64 01/20/01

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 361,739,000 254,636,402 ( 70.39 %) 0 70.39 %

Shareholders

NameEquities%Valuation
FCG Fonder AB
0.2527 %
914,191 0.2527 % 48 681 €
Storebrand Asset Management AS
0.0389 %
140,595 0.0389 % 7 487 €

Company contact information

Active Biotech AB

Scheelevägen 22

223 63, Lund

+46 46 19 20 00

http://www.activebiotech.com
address Active Biotech AB(BTPC)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Bio Therapeutic Drugs

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+17.12% 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+20.63% 115B
ARGENX SE Stock argenx SE
+20.87% 26.64B
BIONTECH SE Stock BioNTech SE
-22.54% 19.91B
GENMAB A/S Stock Genmab A/S
-17.19% 16.32B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-44.74% 15.52B
BEIGENE, LTD. Stock BeiGene, Ltd.
-19.38% 15.49B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+59.18% 14.83B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.19% 13.67B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ACTI Stock
  4. BTPC Stock
  5. Company Active Biotech AB